Search - tctmd.com

Displaying 41 - 60 of 223

Sort: Relevancy | Date

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

News Daily News

SURTAVI Stroke Analysis Published, Confirms Less Early Stroke With TAVR

Todd Neale

October 22, 2018

News Daily News

FDA: All AFX Endovascular AAA Systems Now Under Class I Recall

L.A. McKeown

October 16, 2018

News Opinion Editor's Corner TCT 2018

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

Shelley Wood

October 12, 2018

News Conference News TCT 2018

Human vs Machine: Computer Algorithm Matches Experts for PCI Appropriateness and Planning

Yael L. Maxwell

October 11, 2018

News Industry News

Concept Medical Inc. Raises $60mn For Investigational Device Exemption (IDE) For The World’s First Sirolimus-Coated Balloon

October 10, 2018

News Daily News

FDA Approves BioMimics 3D Stent for Femoropopliteal Artery Disease

Caitlin E. Cox

October 05, 2018

News Industry News

Veryan Medical receives PMA approval for BioMimics 3D

October 05, 2018

News Daily News

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

Caitlin E. Cox

October 04, 2018

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

News Conference News

PREPARE-CALC Shows Benefits of Rotational Atherectomy

TCT Daily Staff

October 01, 2018

News Daily News

Add-on Payment Now in Effect for Sentinel Protection Device During TAVR

Todd Neale

October 01, 2018

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

News Conference News TCT 2018

‘Telestenting’ an Early-Days but Enticing Idea for PCI’s Future

Lucy Hicks

September 27, 2018

News Conference News TCT 2018

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

Todd Neale

September 26, 2018

News Conference News TCT 2018

Higher Risk of Rehospitalization, Mortality in TAVR Patients With Severe Device Mismatch

Lucy Hicks

September 26, 2018

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

News Conference News TCT 2018

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

Yael L. Maxwell

September 25, 2018

News Conference News TCT 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Michael O'Riordan

September 25, 2018

Presentation TCT 2018

Device Therapy Offers a Viable Alternative to Medical Therapy, and Should Be Considered as a Reasonable Alternative!

Presenter: Joost Daemen

September 24, 2018

Advertisement

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

SURTAVI Stroke Analysis Published, Confirms Less Early Stroke With TAVR

FDA: All AFX Endovascular AAA Systems Now Under Class I Recall

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

Human vs Machine: Computer Algorithm Matches Experts for PCI Appropriateness and Planning

Concept Medical Inc. Raises $60mn For Investigational Device Exemption (IDE) For The World’s First Sirolimus-Coated Balloon

FDA Approves BioMimics 3D Stent for Femoropopliteal Artery Disease

Veryan Medical receives PMA approval for BioMimics 3D

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

PREPARE-CALC Shows Benefits of Rotational Atherectomy

Add-on Payment Now in Effect for Sentinel Protection Device During TAVR

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

‘Telestenting’ an Early-Days but Enticing Idea for PCI’s Future

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

Higher Risk of Rehospitalization, Mortality in TAVR Patients With Severe Device Mismatch

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Device Therapy Offers a Viable Alternative to Medical Therapy, and Should Be Considered as a Reasonable Alternative!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content